The Clorox Company $CLX Stock Purchased by Carlson Capital L.P.

Carlson Capital L.P. increased its holdings in The Clorox Company (NYSE:CLX – Free Report) by 53.6% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 133,410 shares of the company’s stock after buying an additional 46,555 shares during the period. Clorox accounts for approximately 2.2% of Carlson Capital L.P.’s portfolio, making the stock its 15th largest holding. Carlson Capital L.P. owned approximately 0.11% of Clorox worth $10,808,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in CLX. Geneos Wealth Management Inc. increased its stake in Clorox by 9.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,402 shares of the company’s stock worth $145,000 after acquiring an additional 119 shares during the last quarter. Elevation Wealth Partners LLC raised its holdings in shares of Clorox by 32.3% in the 3rd quarter. Elevation Wealth Partners LLC now owns 565 shares of the company’s stock valued at $46,000 after acquiring an additional 138 shares in the last quarter. Eastern Bank boosted its position in shares of Clorox by 3.1% during the 3rd quarter. Eastern Bank now owns 5,052 shares of the company’s stock valued at $409,000 after acquiring an additional 150 shares during the last quarter. Mystic Asset Management Inc. boosted its position in shares of Clorox by 1.3% during the 3rd quarter. Mystic Asset Management Inc. now owns 12,112 shares of the company’s stock valued at $981,000 after acquiring an additional 153 shares during the last quarter. Finally, Meeder Advisory Services Inc. boosted its position in shares of Clorox by 5.0% during the 1st quarter. Meeder Advisory Services Inc. now owns 3,228 shares of the company’s stock valued at $335,000 after acquiring an additional 154 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 0.1%

Shares of NYSE:CLX opened at $109.35 on Monday. The stock has a 50 day moving average price of $88.75 and a 200-day moving average price of $99.54. The company has a debt-to-equity ratio of 32.91, a quick ratio of 0.39 and a current ratio of 0.65. The firm has a market capitalization of $13.25 billion, a P/E ratio of 19.67, a P/E/G ratio of 3.46 and a beta of 0.59. The Clorox Company has a 52-week low of $79.12 and a 52-week high of $128.90.

Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings data on Monday, November 2nd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.48. Clorox had a return on equity of 608.30% and a net margin of 9.41%. The business had revenue of $1.91 billion during the quarter, compared to analysts’ expectations of $1.88 billion. During the same quarter in the previous year, the business earned $0.85 earnings per share. The firm’s quarterly revenue was up 33.3% compared to the same quarter last year. As a group, equities research analysts anticipate that The Clorox Company will post 5.74 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Investors of record on Wednesday, October 28th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Wednesday, October 28th. This represents a $5.00 annualized dividend and a dividend yield of 4.6%. Clorox’s dividend payout ratio (DPR) is 89.93%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Wells Fargo & Company boosted their price objective on Clorox from $85.00 to $90.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 3rd. UBS Group set a $88.00 target price on shares of Clorox in a research note on Tuesday, November 3rd. Jefferies Financial Group downgraded shares of Clorox from a “buy” rating to a “hold” rating and lowered their target price for the company from $125.00 to $98.00 in a research note on Tuesday, July 28th. BNP Paribas Exane dropped their target price on shares of Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a research report on Monday, July 20th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 6th. One research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus target price of $93.79.

Get Our Latest Stock Report on CLX

Insider Buying and Selling

In other Clorox news, Director Pierre Breber acquired 4,000 shares of Clorox stock in a transaction that occurred on Wednesday, November 4th. The stock was bought at an average cost of $100.06 per share, for a total transaction of $400,240.00. Following the acquisition, the director owned 22,000 shares of the company’s stock, valued at $2,201,320. This represents a 22.22% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.51% of the company’s stock.

Clorox Company Profile

(Free Report)

The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care. Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt’s Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.